BRCA: Who Should Be Tested? Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out. by Sue Rochman Our Own Words People with cancer and their loved ones find ways for their voices to be heard without filters. by Bradley Jones Finding Support in Unlikely Places After her diagnosis with ovarian cancer, Patricia Anne Ward noticed that some friends and family pulled away. She found connection outside her usual circles. by Patricia Anne Ward Advocacy Spotlight: Sorting Out Priorities Ovarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions. by Cici Zhang Forward Look Little Consensus on Ovarian Cancer Monitoring Tests and scans may be overused. by Kate Yandell Survivor Profile Going Full Bore Susan Leighton, a 19-year survivor, is a powerful advocate for ovarian cancer research. Her advocacy, which began locally in northern Alabama, has reached the National Cancer Institute and the Department of Defense. by Sue Rochman Forward Look Identifying Ovarian Cancer Risk Study may help spotlight women who would benefit from risk reduction strategies. by Carrie Printz Healthy Habits A Cup of Tea? Black tea consumption may be associated with a reduced risk of ovarian cancer. by Kurt Ullman First Person Never Alone: A Family Journey A mother and daughter exchange thoughts about their “full-family experience” facing an ovarian cancer diagnosis and treatment. by Mary (Dicey) Jackson Scroggins and Nneka Scroggins Survivor Profile Regaining Her Balance Gymnast Shannon Miller's focus and agility helped her capture seven Olympic medals before she was 20. But the most decorated U.S. gymnast in history struggled to overcome the shock of her ovarian cancer diagnosis and treatment. by Kevin Begos next Cancer Talk When Cancer Becomes an Unwanted Priority Amanda Rose Ferraro’s leukemia diagnosis forced her to spend time at the hospital away from her 3-year-old-son. She calls focusing on her health and leaving her son “the hardest thing I have ever had to do.” by Amanda Rose Ferraro New Drugs for an Elusive Cancer Target Medical oncologist and lung cancer expert Roy S. Herbst discusses early data on drugs that target a mutated form of the KRAS protein. by Anna Azvolinsky Clinical Trials: An African American Survivor’s Experience Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges. by Melvin Mann Food Insecurity and Cancer After discovering that some patients weren’t able to access the food they needed, a community oncology practice partnered with a local food bank. by Jen Tota McGivney More Posts